GlaxoSmithKline S.A.E (EGX:BIOC)

Egypt flag Egypt · Delayed Price · Currency is EGP
63.10
-0.79 (-1.24%)
At close: Dec 4, 2025
58.22%
Market Cap 5.27B
Revenue (ttm) 3.74B
Net Income (ttm) 98.36M
Shares Out 83.51M
EPS (ttm) 1.17
PE Ratio 53.86
Forward PE n/a
Dividend 0.75 (1.19%)
Ex-Dividend Date n/a
Volume 17,174
Average Volume 64,733
Open 63.89
Previous Close 63.89
Day's Range 63.00 - 64.30
52-Week Range 32.66 - 81.50
Beta 0.98
RSI 40.18
Earnings Date Nov 13, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited. [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 800
Stock Exchange Egyptian Stock Exchange
Ticker Symbol BIOC
Full Company Profile

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.

Financial Statements

News

There is no news available yet.